HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Kwan Park Selected Research
Kwan Park Research Topics
Disease
45
Hemifacial Spasm
12/2023 - 03/2007
17
Neoplasms (Cancer)
09/2012 - 02/2004
11
Glioblastoma (Glioblastoma Multiforme)
08/2011 - 04/2004
8
Hearing Loss (Hearing Impairment)
01/2021 - 05/2011
5
Glioma (Gliomas)
01/2015 - 02/2004
5
Brain Neoplasms (Brain Tumor)
10/2010 - 06/2006
4
Trigeminal Neuralgia (Tic Douloureux)
06/2022 - 04/2007
3
Spasm (Spasms)
01/2022 - 01/2013
2
Cerebrospinal Fluid Leak
08/2023 - 04/2007
2
Craniopharyngioma (Craniopharyngiomas)
07/2012 - 12/2011
2
Disease Progression
08/2010 - 11/2007
2
Melanoma (Melanoma, Malignant)
10/2008 - 01/2008
1
Hematoma
10/2019
1
Paralysis (Palsy)
06/2013
1
Pain (Aches)
03/2013
1
Familial Hemifacial Spasm
01/2013
1
Abducens Nerve Diseases (Sixth Nerve Palsy)
10/2012
1
Cranial Nerve Diseases (Cranial Nerve Disorders)
10/2012
1
Facial Paralysis (Facial Palsy)
10/2012
1
Hydrocephalus (Hydrocephaly)
09/2012
1
Meningitis
12/2011
1
Chordoma
11/2011
1
Optic Nerve Injuries
11/2011
1
Optic Nerve Diseases (Optic Neuropathy)
11/2011
1
Lymphoma (Lymphomas)
10/2011
1
Leukoencephalopathies
10/2011
1
Leukemia
10/2011
1
Genomic Instability
08/2011
1
Meningioma (Meningiomas)
11/2010
1
Neuroepithelial Neoplasms (Gliomatosis Cerebri)
08/2010
1
Teratoma (Teratoid Tumor)
05/2009
1
Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
05/2009
1
Neoplasm Micrometastasis
05/2008
1
Neoplasm Metastasis (Metastasis)
01/2008
1
Craniofacial Abnormalities
11/2007
1
Pituitary Neoplasms (Pituitary Adenoma)
08/2007
1
Adenoma (Adenomas)
08/2007
1
Headache (Headaches)
02/2007
1
Blast Crisis (Blast Phase)
08/2006
1
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2006
1
Body Weight (Weight, Body)
01/2006
1
Oligodendroglioma
05/2005
1
Scurvy (Scorbutus)
11/2004
1
Gliosarcoma
02/2004
Drug/Important Bio-Agent (IBA)
4
Temozolomide (Temodar)
FDA Link
Generic
11/2009 - 01/2006
3
Therapeutic Uses
IBA
10/2008 - 01/2008
3
Paclitaxel (Taxol)
FDA Link
Generic
10/2008 - 06/2006
2
Indicators and Reagents (Reagents)
IBA
02/2015 - 03/2007
2
Proteins (Proteins, Gene)
FDA Link
09/2012 - 01/2009
2
Member 1 Subfamily B ATP Binding Cassette Transporter
IBA
10/2008 - 01/2008
2
Celecoxib (Celebrex)
FDA Link
01/2006 - 02/2004
1
Botulinum Toxins (Botulinum Toxin)
IBA
08/2023
1
Isoflurophate (DFP)
FDA Link
10/2012
1
Anti-Bacterial Agents (Antibiotics)
IBA
12/2011
1
Methotrexate (Mexate)
FDA Link
Generic
10/2011
1
bone wax
IBA
06/2010
1
Tumor Biomarkers (Tumor Markers)
IBA
05/2009
1
Biomarkers (Surrogate Marker)
IBA
05/2009
1
Paraffin
IBA
01/2009
1
A-factor (Streptomyces)
IBA
10/2008
1
vandetanib (ZD6474)
IBA
05/2008
1
ErbB Receptors (EGF Receptor)
IBA
05/2008
1
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
05/2008
1
Cytokines
IBA
03/2008
1
Hormones (Hormone)
IBA
08/2007
1
Imatinib Mesylate (Gleevec)
FDA Link
08/2006
1
Interferon-alpha (Interferon Alfa)
IBA
06/2006
1
Ascorbic Acid (Vitamin C)
FDA Link
Generic
11/2004
1
Antioxidants
IBA
11/2004
1
Thioctic Acid (Lipoic Acid)
IBA
11/2004
1
Messenger RNA (mRNA)
IBA
04/2004
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
04/2004
1
Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
IBA
02/2004
1
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
02/2004
1
Proliferating Cell Nuclear Antigen (PCNA)
IBA
02/2004
Therapy/Procedure
48
Microvascular Decompression Surgery
12/2023 - 03/2007
12
Radiotherapy
09/2012 - 01/2005
7
Therapeutics
10/2011 - 05/2005
5
Drug Therapy (Chemotherapy)
10/2011 - 11/2006
4
Decompression
10/2019 - 11/2011
3
Adjuvant Chemotherapy
08/2010 - 05/2005
2
Salvage Therapy
01/2015 - 05/2008
2
Aftercare (After-Treatment)
05/2009 - 01/2006
1
Craniotomy
10/2019
1
Reoperation
10/2019
1
Transcranial Magnetic Stimulation
12/2018
1
Chemoradiotherapy
10/2009
1
Second-Look Surgery
05/2009
1
Operative Surgical Procedures
11/2007
1
Conservative Treatment
02/2007
1
Oral Administration
02/2004